{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:17:36Z","timestamp":1792113456545,"version":"4.4.0"},"reference-count":11,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Minist\u00e8re de l\u2019\u00c9conomie, de l\u2019Innovation et de l\u2019\u00c9nergie du Qu\u00e9bec"},{"name":"The Hilary & Galen Weston Foundation, Silverstein Foundation, and J. Sebastian van Berkom and Ghislaine Saucier"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns3:p>\n                    The human\n                    <ns3:italic>GBA1<\/ns3:italic>\n                    gene encodes glucocerebrosidase (GCase), a lysosomal enzyme that hydrolyzes glucosylceramides. Variants in\n                    <ns3:italic>GBA1<\/ns3:italic>\n                    and reduced GCase activity have been linked to Parkinson\u2019s disease and Gaucher\u2019s disease. Here we have characterized twenty-four GCase commercial antibodies for western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. These studies are part of a larger, collaborative initiative seeking to address antibody reproducibility issues by characterizing commercially available antibodies for human proteins and publishing the results openly as a resource for the scientific community. While the use of antibodies and protocols vary between laboratories, we encourage readers to use this report as a guide to select the most appropriate antibodies for their specific needs.\n                  <\/ns3:p>","DOI":"10.12688\/f1000research.174230.1","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:54:07Z","timestamp":1765806847000},"page":"1400","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A guide to selecting high-performing antibodies for GCase (UniProt ID: P04062) for use in western blot, immunoprecipitation, and immunofluorescence"],"prefix":"10.12688","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5676-5473","authenticated-orcid":false,"given":"Donovan","family":"Worrall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4611-6134","authenticated-orcid":false,"given":"Charles","family":"Alende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Fothouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3728-3158","authenticated-orcid":false,"given":"Vera Ru\u00edz","family":"Mole\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-8281","authenticated-orcid":false,"given":"Sara Gonz\u00e1lez","family":"Bol\u00edvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham","family":"Ayoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7535-8718","authenticated-orcid":false,"given":"Vincent","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5906-025X","authenticated-orcid":false,"given":"Carl","family":"Laflamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"489-495","DOI":"10.1002\/mds.29314","article-title":"Classification of GBA1 Variants in Parkinson\u2019s Disease: The GBA1-PD Browser.","volume":"38","author":"S Parlar","year":"2023","journal-title":"Mov. Disord."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"458-459","DOI":"10.1002\/humu.9024","article-title":"The identification of eight novel glucocerebrosidase (GBA) mutations in patients with Gaucher disease.","volume":"19","author":"E Orvisky","year":"2002","journal-title":"Hum. Mutat."},{"key":"ref3","article-title":"A consensus platform for antibody characterization.","author":"R Ayoubi","year":"2024","journal-title":"Nat. Protoc."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.12688\/f1000research.141719.1","article-title":"YCharOS open antibody characterisation data: Lessons learned and progress made.","volume":"12","author":"M Biddle","year":"2023","journal-title":"F1000Res."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.48363","article-title":"Implementation of an antibody characterization procedure and application to the major ALS\/FTD disease gene C9ORF72.","volume":"8","author":"C Laflamme","year":"2019","journal-title":"elife."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"977","DOI":"10.12688\/f1000research.124632.1","article-title":"Identification of highly specific antibodies for Serine\/threonine-protein kinase TBK1 for use in immunoblot, immunoprecipitation and immunofluorescence.","volume":"11","author":"W Alshafie","year":"2022","journal-title":"F1000Res."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.7554\/eLife.91645.2","article-title":"Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications.","volume":"12","author":"R Ayoubi","year":"2023","journal-title":"elife."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"65-78","DOI":"10.3233\/JPD-230295","article-title":"Characterization of Novel Human beta-glucocerebrosidase Antibodies for Parkinson\u2019s Disease Research.","volume":"14","author":"T Jong","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"D358-D367","DOI":"10.1093\/nar\/gkac927","article-title":"The Antibody Registry: ten years of registering antibodies.","volume":"51","author":"A Bandrowski","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"25-38","DOI":"10.7171\/jbt.18-2902-002","article-title":"The Cellosaurus, a Cell-Line Knowledge Resource.","volume":"29","author":"A Bairoch","year":"2018","journal-title":"J. Biomol. Tech."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"100-106","DOI":"10.1038\/s41592-020-01018-x","article-title":"Cellpose: a generalist algorithm for cellular segmentation.","volume":"18","author":"C Stringer","year":"2021","journal-title":"Nat. Methods."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/14-1400\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/14-1400\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/14-1400\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:24:09Z","timestamp":1768281849000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/14-1400\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":11,"URL":"https:\/\/doi.org\/10.12688\/f1000research.174230.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.192114.r446553","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.192114.r442397","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.192114.r446553","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.192114.r442397","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/14-1400\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.192114.r442397, Deborah Moshinsky, Institute for Protein Innovation, Boston, Massachusetts, 10 Jan 2026, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/14-1400\/v1#referee-response-442397","order":0,"name":"referee-response-442397","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.192114.r446553, Karen Bowman, University of Leicester, Leicester, England, 13 Jan 2026, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/14-1400\/v1#referee-response-446553","order":1,"name":"referee-response-446553","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This research was partly funded by the G-Can (GBA1-Canada) initiative, an open-science collaboration dedicated to advancing research on Parkinson's disease associated with GBA1 mutations. G-Can is supported by The Hilary & Galen Weston Foundation, Silverstein Foundation, and J. Sebastian van Berkom and Ghislaine Saucier. This work was also supported by the Quebec Consortium for Drug Discovery (CQDM), a grant from the Minist\u00e8re de l\u2019\u00c9conomie, de l\u2019Innovation et de l\u2019\u00c9nergie du Qu\u00e9bec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}